Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: a Preliminary Study with Clinical Relevance

MLA

Beatriz García, et al. “Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: A Preliminary Study with Clinical Relevance.” Pathology & Oncology Research, vol. 26, Feb. 2018, pp. 167–73. EBSCOhost, https://doi.org/10.1007/s12253-018-0387-7.

APA

Beatriz García, Isabel Guerra-Merino, Francisco Borja Gutiérrez-Corres, José Javier Aguirre, Jorge Santos-Juanes, Luis M. Quirós, Laura Lorente-Gea, Iván Fernández-Vega, & Emma Camacho-Urkaray. (2018). Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: a Preliminary Study with Clinical Relevance. Pathology & Oncology Research, 26, 167–173. https://doi.org/10.1007/s12253-018-0387-7

Chicago

Beatriz García, Isabel Guerra-Merino, Francisco Borja Gutiérrez-Corres, José Javier Aguirre, Jorge Santos-Juanes, Luis M. Quirós, Laura Lorente-Gea, Iván Fernández-Vega, and Emma Camacho-Urkaray. 2018. “Miki (Mitotic Kinetics Regulator) Immunoexpression in Normal Liver, Cirrhotic Areas and Hepatocellular Carcinomas: A Preliminary Study with Clinical Relevance.” Pathology & Oncology Research 26 (February): 167–73. doi:10.1007/s12253-018-0387-7.